(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.
Tiepolt S, Becker GA, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J, Wagenknecht G, Sattler B, Deuther-Conrad W, Ludwig FA, Fischer S, Gertz HJ, Smits R, Hoepping A, Steinbach J, Brust P, Sabri O.
Tiepolt S, et al. Among authors: gertz hj.
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):731-746. doi: 10.1007/s00259-020-05029-w. Epub 2020 Sep 16.
Eur J Nucl Med Mol Imaging. 2021.
PMID: 32935187
Free PMC article.